Cargando…

Causality of small and large intestinal microbiota in weight regulation and insulin resistance

OBJECTIVE: The twin pandemics of obesity and Type 2 diabetes (T2D) are a global challenge for health care systems. Changes in the environment, behavior, diet, and lifestyle during the last decades are considered the major causes. A Western diet, which is rich in saturated fat and simple sugars, may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheithauer, Torsten P.M., Dallinga-Thie, Geesje M., de Vos, Willem M., Nieuwdorp, Max, van Raalte, Daniël H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004227/ https://www.ncbi.nlm.nih.gov/pubmed/27617199 http://dx.doi.org/10.1016/j.molmet.2016.06.002

Ejemplares similares

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance
por: Surendran, R. Preethi, et al.
Publicado: (2018)

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
por: Udayappan, Shanthadevi, et al.
Publicado: (2016)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Effects of imatinib on vascular insulin sensitivity and free fatty acid transport in early weight gain
por: Box, Camiel V. J., et al.
Publicado: (2021)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
por: Bouter, Kristien E. C., et al.
Publicado: (2020)

Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy
por: Schnitzler, Johan G., et al.
Publicado: (2017)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
por: Smits, Loek P., et al.
Publicado: (2018)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females
por: Zhang, Xiang, et al.
Publicado: (2018)

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes
por: Habibe, Jayron J., et al.
Publicado: (2022)

Intestinal Ralstonia pickettii augments glucose intolerance in obesity
por: Udayappan, Shanthadevi D., et al.
Publicado: (2017)

The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro
por: Dallinga, Marchien G., et al.
Publicado: (2021)

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
por: de Groot, Pieter F., et al.
Publicado: (2017)

In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)

The Endoplasmic Reticulum Coat Protein II Transport Machinery Coordinates Cellular Lipid Secretion and Cholesterol Biosynthesis
por: Fryer, Lee G. D., et al.
Publicado: (2014)

Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume
por: Bernelot Moens, Sophie J., et al.
Publicado: (2014)

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
por: Koopen, Annefleur M., et al.
Publicado: (2021)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study
por: Singh, Ramandeep, et al.
Publicado: (2018)

Pancreatic (18)F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
por: Bakker, Guido J., et al.
Publicado: (2019)

Mouse models for human intestinal microbiota research: a critical evaluation
por: Hugenholtz, Floor, et al.
Publicado: (2017)

Intestinal microbiota in human health and disease: the impact of probiotics
por: Gerritsen, Jacoline, et al.
Publicado: (2011)

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report
por: Reeskamp, Laurens F., et al.
Publicado: (2021)

Fecal microbiota transplantation and fiber supplementation, better together?
por: Hanssen, Nordin M.J., et al.
Publicado: (2021)

Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
por: Liu, Moyan, et al.
Publicado: (2022)

Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study
por: Lankelma, Jacqueline M., et al.
Publicado: (2016)

Fecale microbiota transplantatie, meer dan een behandeling voor Clostridium difficile?
por: Nieuwdorp, Max
Publicado: (2020)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Elevated Lipoprotein(a) in Perinatally HIV-Infected Children Compared With Healthy Ethnicity-Matched Controls
por: Van den Hof, Malon, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms
por: Jalanka-Tuovinen, Jonna, et al.
Publicado: (2011)

Intestinal Microbiota and Weight-Gain in Preterm Neonates
por: Arboleya, Silvia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2dl3r4gakejfa138afu73b9uon